Inclusion of hepatitis C virus testing in National Health Screening to accelerate HCV elimination in South Korea

Jee, Youngmee

doi:10.35772/ghm.2021.01057

Cited by 3 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Anti-hepatitis C virus antibody positivity (2015-2019) [4,5] Figure 2. Newly registered patients with chronic hepatitis C at the Korea Disease Control and Prevention Agency in 2019 [4,5] Figure 3.…”

Section: Figurementioning

confidence: 99%

“…Newly registered patients with chronic hepatitis C at the Korea Disease Control and Prevention Agency in 2019 [4,5] Figure 3. Chronic hepatitis antiviral treatment rate by gender and age (2019) [4,5] 증가하며, 80-89세 연령층에서는 41%에 달한다는 보고가 있 고 [6], 이집트에서는 60세 이상의 anti-HCV 항체 양성률이 40%에 달한다는 보고가 있다 [2]. 노인에서의 만성 C형간염 은 간경변증으로 진행이 빠르고 [7] 이에 따른 간세포암종 발행의 위험도가 높아질 수 있으며 [8]…”

Section: Figureunclassified

See 1 more Smart Citation

Treatment of Chronic Hepatitis C in Older Adults

Yeon

2023

Korean J Clin Geri

View full text Add to dashboard Cite

Worldwide, more than 100 million people were infected with chronic hepatitis C (CHC). Prevalence in Korea was estimated at as much as 0.6%. Because of the progressive aging of hepatitis C virus-infected people, the number of cases of CHC in older adults has been increasing. In older patients with CHC, greater acceleration of fibrosis with aging and higher risk of hepatocellular carcinoma development have been reported. Currently, with the popular all-oral combination of direct-acting antiviral (DAA) treatment of CHC, the rates of sustained virologic response and treatment-related adverse events between patients younger and older than 65 years are not significantly different. Although clinicians should consider drug-drug interactions, comorbid medical condition, risk of disease progression, and long-term benefits of viral eradication by DAA, older age should not be a barrier to treatment.

show abstract